您的位置：
首页
>
农业专利
>
详情页
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
专利权人:
Pfizer Inc.
发明人:
Spiros Liras,Vincent Mascitti,Benjamin Thuma
申请号：
US16023232
公开号：
US10376531B2
申请日:
2018.06.29
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Compounds of Formula (A) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by pharmaceutical compositions and the uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
SUBSTITUTED-6,8-DIOXABICYCLO [3.2.1.]OCTANE-2,3-DIOL COMPOUNDS AS AGENTS AIMED AT ASGPR
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
SUBSTITUTED-6,8-DIOXABICYCLO[3.2.1]OCTANE-2,3-DIOL COMPOUNDS AS TARGETING AGENTS OF ASGPR
SUBSTITUTED-6,8-DIOXABICYCLO[3.2.1]OCTANE-2,3-DIOL COMPOUNDS AS TARGETING AGENTS OF ASGPR
SUBSTITUTED-6,8-DIOXABICYCLO[3.2.1]OCTANE-2,3-DIOL COMPOUNDS AS TARGETING AGENTS OF ASGPR
